*Some Market data delayed by 15 mins.

Annexon, Inc. Common Stock

Symbol: ANNX (NASDAQ)
3.14 ▲ (2.79%) 0.085

Company Description:
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Key Stats
  • Today's Open: $3.02
  • Today's High: $3.164
  • Today's Low: $2.91
  • Today's Volume: 280.03K
  • Yesterday Close: $3.05
  • Yesterday High: $3.14
  • Yesterday Low: $2.91
  • Yesterday Volume: 2.94M
  • Last Min Volume: 12.51K
  • Last Min High: $3.145
  • Last Min Low: $3.136
  • Last Min VWAP: $3.14494
Company Profile
  • Name: Annexon, Inc. Common Stock
  • Website: https://www.annexonbio.com
  • Listed Date: 2020-07-24
  • Location: BRISBANE, CA
  • Market Status: Active
  • CIK Number: 0001528115
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $335.15M
  • Round Lot: 100
  • Outstanding Shares: 109.89M
  • Asset Type: CS
RECENT FILINGS FOR ANNX
Filing Date Filing Type Format
2025-09-04 4 View
2025-08-14 10-Q View
2025-08-14 8-K View
2025-08-14 SCHEDULE 13G/A View
2025-08-06 SCHEDULE 13G/A View
2025-08-01 4 View
2025-07-16 4 View
2025-07-16 4 View
2025-07-16 4 View
2025-07-14 144 View
2025-07-14 144 View
2025-07-14 144 View
2025-07-01 4 View
2025-06-25 8-K View
2025-06-09 4 View
2025-06-09 4 View
2025-06-09 4 View
2025-06-09 4 View
2025-06-09 4 View
2025-06-09 4 View
Latest News on ANNX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.